Lapatinib

Lapatinib
Lapatinib
Lapatinib

Lapatinib

Min.Order / FOB Price:Get Latest Price

100 Metric Ton

Negotiable

  • Min.Order :100 Metric Ton
  • Purity: 98%min
  • Payment Terms : L/C,T/T,Other

Keywords

231277-92-2 Lapatinib seller in China Sell high quality 231277-92-2 produced in China factory

Quick Details

  • Appearance:white powder
  • Application:Used for research and industrial manufacture.
  • PackAge:As customer request
  • ProductionCapacity:100|Metric Ton|Day
  • Storage:Store in a cool,dry place and keep away from direct strong light
  • Transportation:Common products:Sea/Air/Courier Dangerous Chem:Sea/Air

Superiority:

Triumph Chemical Title

Triumph Company Office picture

Triumph Company advantage

Triumph Testing title picture

Triumph Testing way

 

Welcome to contact us

Lorcaserin(856681-05-5)is an orally administered agent and a selective 5-HT2C receptor agonist for the treatment of obesity. It had been approved for marketing in US by FDA on 27 June in 2012. In clinical studies, lorcaserin has demonstrated efficacy in obese and overweight populations by promoting weight loss and improving metabolic parameters, and it is well tolerated.

Details:

Details

Specifications
Lapatinib 
1.CAS:231277-92-2 
2.Purity:99% 
3.White powder 
4.for breast cancer and other solid tumours
Lapatinib
CAS-No.:231277-92-2
Molecular Formula:C29H26ClFN4O4S
Molecular Weight:581.0575432
Purity:99%
Appearance:White to yellow powder 


Lapatinib is an orally active drug for breast cancer and other solid tumours. It is a dual tyrosine kinase inhibitor which interrupts the HER2 growth receptor pathway. It is used in combination therapy for HER2-positive breast cancer. It is used for the treatment of patients with advanced or metastatic breast cancer whose tumors overexpress HER2 (ErbB2)


Specifications
Lapatinib 
1.CAS:231277-92-2 
2.Purity:99% 
3.White powder 
4.for breast cancer and other solid tumours
Lapatinib
CAS-No.:231277-92-2
Molecular Formula:C29H26ClFN4O4S
Molecular Weight:581.0575432
Purity:99%
Appearance:White to yellow powder 


Lapatinib is an orally active drug for breast cancer and other solid tumours. It is a dual tyrosine kinase inhibitor which interrupts the HER2 growth receptor pathway. It is used in combination therapy for HER2-positive breast cancer. It is used for the treatment of patients with advanced or metastatic breast cancer whose tumors overexpress HER2 (ErbB2)

 

View All
Visit Store

You Might Also Like

Related Searches

Contact Supplier

Confirm to collect the product to my collection?

OKCancel

About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia

Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog

©2008 LookChem.com,License: ICP

NO.:Zhejiang16009103

complaints:service@lookchem.com Desktop View